162 related articles for article (PubMed ID: 38772212)
1. CNOT7 regulates lipid deposition in nonalcoholic fatty liver disease.
Li J; Wen W; Li J; Liu T; Sun J; Chen H
Biochem Biophys Res Commun; 2024 Aug; 721():150003. PubMed ID: 38772212
[TBL] [Abstract][Full Text] [Related]
2. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
3. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway.
Gai H; Zhou F; Zhang Y; Ai J; Zhan J; You Y; Huang W
J Food Sci; 2020 Nov; 85(11):4050-4060. PubMed ID: 33037652
[TBL] [Abstract][Full Text] [Related]
4. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
5. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
6. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
7. CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex.
Stoney PN; Yanagiya A; Nishijima S; Yamamoto T
J Mol Biol; 2022 May; 434(9):167523. PubMed ID: 35248544
[TBL] [Abstract][Full Text] [Related]
8. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
9. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
10. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
11. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L
Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144
[TBL] [Abstract][Full Text] [Related]
12. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
[TBL] [Abstract][Full Text] [Related]
13. Saturated Fatty Acid-Induced Impairment of Hepatic Lipid Metabolism Is Worsened by Prohibitin 1 Deficiency in Hepatocytes.
Yanran W; Jung S; Ko KS
J Med Food; 2022 Aug; 25(8):845-852. PubMed ID: 35980329
[TBL] [Abstract][Full Text] [Related]
14. The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation.
Aslam A; Mittal S; Koch F; Andrau JC; Winkler GS
Mol Biol Cell; 2009 Sep; 20(17):3840-50. PubMed ID: 19605561
[TBL] [Abstract][Full Text] [Related]
15. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
16. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
17. Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/apoER2 Pathway.
Gu L; Zhang Y; Zhang S; Zhao H; Wang Y; Kan D; Zhang Y; Guo L; Lv J; Hao Q; Tian X; Liu C; Wang S; Han X
J Oleo Sci; 2021 May; 70(5):685-696. PubMed ID: 33840662
[TBL] [Abstract][Full Text] [Related]
18. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1.
Zhou JP; Ren YD; Xu QY; Song Y; Zhou F; Chen MY; Liu JJ; Chen LG; Pan JS
Biomed Res Int; 2020; 2020():4087928. PubMed ID: 31998789
[TBL] [Abstract][Full Text] [Related]
19. Silencing of CCR4-NOT complex subunits affects heart structure and function.
Elmén L; Volpato CB; Kervadec A; Pineda S; Kalvakuri S; Alayari NN; Foco L; Pramstaller PP; Ocorr K; Rossini A; Cammarato A; Colas AR; Hicks AA; Bodmer R
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32471864
[TBL] [Abstract][Full Text] [Related]
20. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
